HIV/AIDS News

More HIV/AIDS News
 
 
 
Sign Up: sign upDaily News Email
 

Top Stories

  • Stable Soft-Tissue Filler Stimulates an Immune Response Calcium hydroxylapatite, which has been approved for facial cosmetic indications, stimulates an immune response with lymphocytic infiltration and foreign body giant cell formation.
    Medscape Medical News, September 16, 2008
  • Abacavir May Be Less Effective in HIV Patients With High Viral Load In the ACTG 5202 trial, abacavir may have lead to a higher rate of virologic failure in patients with a high viral load, although a separate company-supported trial shows a different view.
    Medscape Medical News, August 13, 2008
  • Abacavir May Increase Risk for CVD in Subset of Patients In an analysis of the SMART trial, long-term use of abacavir was associated with increased cardiovascular disease risk and higher levels of IL-6 and hs-CRP in a subset of patients. However, a company-funded study found the opposite.
    Medscape Medical News, August 12, 2008
  • Progress Made on 3 Second-Generation NNRTIs New second-generation nonnucleoside reverse transcriptase inhibitors, some of which show activity against HIV strains resistant to current first-line therapy, continue to show promise.
    Medscape Medical News, August 11, 2008
 
 

Other Medical News

 

Business of Medicine News

 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.